The involvement of the Rho-kinase pathway and its regulation in cytokine-induced collagen gel contraction by hyalocytes

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 11, 2004, Pages 3896-3903

  Hirayama, Kumiko ^a   Hata, Yasuaki ^a   Noda, Yoshihiro ^a   Miura, Muneki ^a   Yamanaka, Ichiro ^a   Shimokawa, Hiroaki ^a   Ishibashi, Tatsuro ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ALPHA ACTIN; COLLAGEN GEL; CYTOKINE; PLATELET DERIVED GROWTH FACTOR BB; RHO KINASE; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL CELL; ARTICLE; CATTLE; CELL DIFFERENTIATION; CELL SHAPE; HYALOCYTE; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; VITREOUS BODY;

ACTINS; ANIMALS; BLOTTING, WESTERN; CATTLE; CELLS, CULTURED; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GELS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGES; MYOSIN LIGHT CHAINS; PHOSPHORYLATION; PLATELET-DERIVED GROWTH FACTOR; PROTEIN-SERINE-THREONINE KINASES; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA2; VITREOUS BODY;

EID: 6944253469     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-1330     Document Type: Article

References (48)

1. Balazs EA, Toth LZ, Ozanics V. Cytological studies on the developing vitreous as related to the hyaloid vessel system. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1980;213:71-85.
2. Lazarus HS, Hangeman GS. In situ characterization of the human hyalocyte. Arch Ophthalmol. 1994;112:1356-1362.
3. Zhu M, Penfold PL, Madigan MC, Billson FA. Effect of human vitreous and hyalocyte-derived factors on vascular endothelial cell growth. Aust NZ J Ophthalmol. 1997;25(suppl 1):S57-S60.
4. Grabner G, Blotz G, Forster O. Macrophage-like properties of human hyalocytes. Invest Ophthalmol Vis Sci. 1980; 19:333-340.
5. Mitchell CA, Risau W, Drexler HC. Regression of vessels in the tunica vasculosa lentis is initiated by coordinated endothelial apoptosis: a role for vascular endothelial growth factor as a survival factor for endothelium. Dev Dyn 1998;213:322-333.
6. Lang RA, Bishop JM. Macrophages are required for cell death and tissue remodelling in the developing mouse eye. Cell. 1993;74: 453-462.
7. Kampik A, Kenyon KR, Michels RG, Green WR, de la Cruz ZC. Epiretinal and vitreous membranes: comparative study of 56 cases. Arch Ophthalmol. 1981;99:1445-1454.
8. Kampik A, Green WR, Michels RG, Nase PK. Ultrastructural features of progressive idiopathic epiretinal membrane removed by vitreous surgery. Am J Ophthalmol. 1980;90:797-809.
9. Faulborn J, Dunker S, Bowald S. Diabetic vitreopathy: findings using the celloidin embedding technique. Ophthalmologica. 1998;212:369-376.
10. Jerdan JA, Pepose JS, Michels RG, et al. Proliferative vitreoretinopathy membranes: an immunohistochemical study. Ophthalmology. 1989;96:801-810.
11. Machemer R, Laqua H. Pigment epithelium proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol. 1975;80:1-23.
12. Vinores SA, Campochiaro PA, Conway BP. Ultrastructural and electron-immunocytochemical characterization of cells in epiretinal membranes. Invest Ophthalmol Vis Sci. 1990;31:14-28.
13. Weller M, Heimann K, Wiedemann P. Mononuclear phagocytes and their growth factors: pacemakers of proliferative vitreoretinopathy? Klin Monatsbl Augenheilkd. 1990;196:121-127.
14. Ando A, Ueda M, Uyama M, Masu Y, Ito S. Enhancement of dedifferentiation and myoid differentiation of retinal pigment epithelial cells by platelet derived growth factor. Br J Ophthalmol. 2000;84:1306-1311.
15. Connor TB Jr, Roberts AB, Sporn MB, et al. Correlation of fibrosis and transforming growth factor-β type 2 levels in the eye. J Clin Invest. 1989;83:1661-1666.
16. Robbins SG, Mixon RN, Wilson DJ, et al. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. Invest Ophthalmol Vis Sci. 1994;35:3649-3663.
17. Vinores SA, Henderer JD, Mahlow J, et al. Isoforms of platelet-derived growth factor and its receptors in epiretinal membranes: immunolocalization to retinal pigmented epithelial cells. Exp Eye Res. 1995;60:607-619.
18. Ikuno Y, Kazlauskas A. An in vivo gene therapy approach for experimental proliferative vitreoretinopathy using the truncated platelet-derived growth factor α receptor. Invest Ophthalmol Vis Sci. 2002;43:2406-2411.
19. Xu J, Clark RA. Extracellular matrix alters PDGF regulation of fibroblast integrins. J Cell Biol. 1996;132:239-249.
20. Jester JV, Ho-Chang J. Modulation of cultured corneal keratocyte phenotype by growth factors/cytokines control in vitro contractility and extracellular matrix contraction. Exp Eye Res. 2003;77: 581-592.
21. Kamm KE, Stull JT. The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Annu Rev Pharmacol Toxicol. 1985;25:593-620.
22. Huttenlocher A, Sandborg RR, Horwitz AF. Adhesion in cell migration. Curr Opin Cell Biol. 1995;7:697-706.
23. Amano M, Ito M, Kimura K, et al. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem. 1996;271:20246-20249.
24. Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle. Nature. 1994;372:231-236.
25. Kohama K, Ye L-H, Hayakawa K, Okagaki T. Myosin light chain kinase: an actin-binding protein that regulates an ATP-dependent interaction with myosin. Trends Biochem Sci. 1996;17:284-287.
26. Bresnick AR. Molecular mechanisms of nonmuscle myosin-II regulation. Curr Opin Cell Biol. 1999;11:26-33.
27. Kimura K, Ito M, Amano M, et al. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science. 1996; 273:245-248.
28. Morishige K, Shimokawa H, Eto Y, et al. Adenovirus-mediated transfer of dominant-negative rho-kinase induces a regression of coronary arteriosclerosis in pigs in vivo. Arterioscler Thromb Vasc Biol. 2001;21:548-554.
29. Kaibuchi K, Kuroda S, Amano M. Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu Rev Biochem. 1999;68:459-486.
30. Somlyo AP, Somlyo AV. Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol (Lond). 2000;522:177-185.
31. Shimokawa H. Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases. J Cardiovasc Pharmacol. 2002; 39:319-327.
32. Fukata Y, Amano M, Kaibuchi K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci. 2001;22:32-39.
33. van Nieuw Amerongen GP, van Hinsbergh VW. Cytoskeletal effects of Rho-like small guanine nucleotide-binding proteins in the vascular system. Arterioscler Thromb Vasc Biol. 2001;21:300-311.
34. Shimokawa H, Seto M, Katsumata N, et al. Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm. Cardiovasc Res. 1999; 43:1029-1039.
35. Salu P, Claeskens W, De Wilde A, Hijmans W, Wisse E. Light and electron microscopic studies of the rat hyalocyte after perfusion fixation. Ophthalmic Res. 1985;17:125-130.
36. Noda Y, Hata Y, Hisatomi T, et al. Functional properties of hyalocytes under PDGF-rich conditions. Invest Ophthalmol Vis Sci. 2004;45:2107-2114.
37. Hata Y, Rock SL, Aiello LP. Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogenactivated protein kinase-dependent pathway. Diabetes. 1999;48:1145-1155.
38. Carrington L, McLeod D, Boulton M. IL-10 and antibodies to TGF-beta2 and PDGF inhibit RPE-mediated retinal contraction. Invest Ophthalmol Vis Sci. 2000;41:1210-1216.
39. Campochiaro PA, Hackett SF, Vinores SA, et al. Platelet-derived growth factor is an autocrine growth stimulator in retinal pigmented epithelial cells. J Cell Sci. 1994;107:2459-2469.
40. Cassidy L, Barry P, Shaw C, Duffy J, Kennedy S. Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders. Br J Ophthalmol. 1998;82:181-185.
41. Baudouin C, Fredj-Reygrobellet D, Brignole F, Negre F, Lapalus P, Gastaud P. Growth factors in vitreous and subretinal fluid cells from patients with proliferative vitreoretinopathy. Ophthalmic Res. 1993;25:52-59.
42. Smiddy WE, Maguire AM, Green WR, et al. Idiopathic epiretinal membranes: ultrastructural characteristics and clinicopathologic correlation. Ophthalmology 1989;96:811-820.
43. Mohri M, Shimokawa H, Hirakawa Y, Masumoto A, Takeshita A. Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm. J Am Coll Cardiol. 2003;41:15-19.
44. Uehata M, Ishizaki T, Satoh H, et al. Calcium sensitization of smooth muscle mediated by a rho-associated protein kinase in hypertension. Nature. 1997;389:990-994.
45. Limb GA, Little BC, Meager A, et al. Cytokines in proliferative vitreoretinopathy. Eye. 1991;5:686-693.
46. Wiedemann P. Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration. Surv Ophthalmol. 1992;36:373-384.
47. Limb GA, Alam A, Barley O, Green W, Chignell AH, Dumonde DC. Distribution of cytokine proteins within epiretinal membranes in proliferative vitreoretinopathy. Curr Eye Res. 1994; 13:791-798.
48. Elner SG, Einer VM, Jaffe GJ, Stuart A, Kunkel SL, Stricter RM. Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Curr Eye Res. 1995;14:1045-1053.